Those with HPLC but not IN detectable albuminuria had higher BP, worse glycaemic control and more vascular events (p < 0.05 for all) but received fewer vascular risk reduction treatments.
Those with HPLC but not IN detectable albuminuria had higher BP, worse glycaemic control and more vascular events (p < 0.05 for all) but received fewer vascular risk reduction treatments.